Navigation Links
Radiation And Chemotherapy, A Better Option For Head And Neck Cancer

A new study appearing in the December 1, 2005, issue of the International Journal of Radiation Oncology*Biology* Physics, says that a combination of radiation therapy // and chemotherapy could avert speech problems in head and neck cancer patients.

The journal, which is the official publication of the American Society for Therapeutic Radiology and Oncology (ASTRO), adds that this combination approach is better than radical surgery, which sometimes necessitates the removal of the vocal cords in the larynx. These findings were made by doctors at the University of Michigan in Ann Arbor, Mich, who monitored 97 patients with advanced laryngeal cancer in the Department of Otolaryngology – Head and Neck Surgery. All these patients were initially put on chemotherapy and after assessment of their response were either treated with radiation or surgery.

The doctors found that patients who did not undergo surgery and took radiation therapy has a better timbre of voice than patients who had their larynx removed. The swallowing function of both thr groups was pretty much the same, but patients with an intact larynx were able to understand speech better. Commenting on these findings, Kevin Fung, the lead author of the study and currently a Head and Neck Surgeon at the University of Western Ontario in London, Ontario, Canada said, “Undergoing the radiation, chemotherapy combination can increase toxicity levels in some patients, but maintaining the overall quality of life for those patients justifies the potential for added toxicity.'

It was also found that 89 percent of patients who underwent radiation were able to obtain essential nutrients orally, while only 64 percent of the laryngectomy patients were able to do so, “The overall survival rate is high for both sets of patients but those patients who respond well to the initial treatments and can avoid the surgery also avoid the social, emotional and physical side effects such as cosmetic disfigurem ent and speech alteration,” concluded Fung.

'"/>




Related medicine news :

1. Radiation before surgery cuts cancer recurrence
2. UV Radiation induces Melanoma
3. Radiation reduces cancer recurrence
4. Radiation before surgery cuts cancer reappearance
5. Radiation Not Needed for Childhood Cancers
6. Does Radiation Cause Lung Cancer?
7. Radiation for Bone Pain
8. Radiation for Bone Pain
9. Radiation after Breast Reconstruction
10. Radiation Exposure Found To Affect Intellect Later In Life
11. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of the ... 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs ... across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... operations executives and focusing on all facets of clinical trial planning and management. ... , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were ...
(Date:2/17/2017)... ... 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from around the ... - 23 in Beaver Creek, CO. It was announced today by Cindy Lovelace, executive ... Beaver Creek, hosting over 60 faculty members and addressing unmet needs of the NET ...
(Date:2/16/2017)... ... February 17, 2017 , ... ... last long after their final treatments. Physician researchers at The Marcus Institute ... a mind-body therapy, for efficacy in reducing symptoms of traumatic stress in cancer ...
(Date:2/16/2017)... ... February 16, 2017 , ... Doctors on Liens is proud ... their network through his work at BKP Chiropractic in Lancaster . ... degree from Canada’s prestigious International Baccalaureate Program, Dr. Raj went on to open ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , February 17, 2017 Cryoablation, Electrical, ... The global ablation technologies market is expected to grow ... from 2022-2027. The market is expected to grow at a CAGR ... $3.3bn in 2016, and $9.05bn in 2026. ... How this report will benefit you ...
(Date:2/17/2017)... , February 17, 2017 According to ... Particle Counters, Liquid Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of ... to 2021" published by MarketsandMarkets, the market is expected to reach ... at a CAGR of 3.7% from 2016 to 2021. ... ...
(Date:2/17/2017)... 17, 2017 Theravance Biopharma, Inc. (NASDAQ: ... "Company") today announced the presentation of positive clinical ... administered pan-Janus kinase (JAK) inhibitor designed to be ... of the European Crohn,s and Colitis Organization (ECCO). ... data from its completed Phase 1 study of ...
Breaking Medicine Technology: